Stenman Adam, Kjellman Magnus, Zedenius Jan, Juhlin C Christofer
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden.
Thyroid Res. 2022 Feb 4;15(1):1. doi: 10.1186/s13044-022-00120-w.
Follicular thyroid carcinomas (FTCs) rarely metastasize to regional lymph nodes, and descriptions of synchronous lateral lymph node metastases of FTC and papillary thyroid carcinoma (PTC) are lacking.
We describe a 43-year-old female with a preoperative cytology indicating a right-sided PTC with lateral lymph node metastases. She underwent a total thyroidectomy and central and lateral lymph node dissection, and histopathology confirmed a multifocal tall cell variant PTC together with a 12 mm minimally invasive FTC in the ipsilateral lobe. While the central compartment demonstrated metastatic PTC, the lateral compartment contained PTC metastases alongside a 15 mm large follicular-patterned mass in a separate lymph node. As the cells lacked PTC associated nuclear changes, the possibility of a lateral lymph node metastasis of FTC was considered, with the possibility of ectopic thyroid tissue as a differential diagnosis. By utilizing next-generation sequencing, a Q61R NRAS mutation was pinpointed, thus proving the tissue as tumorous. The patient underwent radioiodine treatment and is currently monitored following a negative whole-body scan.
This is probably the first case report of a patient with co-existing lateral lymph node PTC and FTC metastases. Consulting previous publications, there is currently a gap of knowledge in terms of how patients with regional FTC metastases should be followed-up and treated, especially when co-occurring with spread high-risk PTC subtypes. Moreover, what guides a seemingly indolent FTC to spread via the lymphatic system remains to be defined from a molecular standpoint.
滤泡性甲状腺癌(FTC)很少转移至区域淋巴结,且缺乏关于FTC与乳头状甲状腺癌(PTC)同步发生侧方淋巴结转移的描述。
我们描述了一名43岁女性,术前细胞学检查提示右侧PTC伴侧方淋巴结转移。她接受了全甲状腺切除术及中央区和侧方淋巴结清扫术,组织病理学证实为多灶性高细胞变异型PTC,同侧叶还有一个12毫米的微小浸润性FTC。中央区显示有转移性PTC,而侧方区除一个单独淋巴结中有一个15毫米大的滤泡样肿块外,还含有PTC转移灶。由于细胞缺乏与PTC相关的核变化,考虑为FTC侧方淋巴结转移的可能性,鉴别诊断为异位甲状腺组织。通过下一代测序,确定了一个Q61R NRAS突变,从而证明该组织为肿瘤性。患者接受了放射性碘治疗,目前全身扫描阴性,正在接受监测。
这可能是首例同时存在侧方淋巴结PTC和FTC转移的患者的病例报告。查阅既往文献,目前在区域FTC转移患者应如何随访和治疗方面存在知识空白,尤其是当与高风险PTC亚型扩散同时发生时。此外,从分子角度来看,是什么因素导致看似惰性的FTC通过淋巴系统扩散仍有待确定。